drug · small molecule
paxalisib
Phase 3updated 3mo agoby $KZIA KAZIA THERAPEUTICS LTD🔗 ChEMBL
Phase 3community read0 votes
Small molecule drug with a maximum clinical stage of Phase 2 (across all indications), with 5 investigational indications.
targets
PI3-kinase class I
all catalysts(0)
nothing on the calendar yet
Trials studying paxalisib
- phase3A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
- phase2Genetic Testing in Guiding Treatment for Patients With Brain Metastases
- phase25G-PEARL: Paxalisib in Malignant Brain Tumours
- phase2Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer
- phase2Paxalisib With a High Fat, Low Carb Diet and Metformin for Glioblastoma
- phase2Combination Therapy for the Treatment of Diffuse Midline Gliomas
- phase2Paxalisib (GDC-0084) In Recurrent Or Refractory PCNSL
- phase2Safety, Pharmacokinetics and Efficacy of Paxalisib (GDC-0084) in Newly-diagnosed Glioblastoma
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 47m ago
Found something off?
comments(0)
5-min edit window · permanent after that